Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma

Wang, F; Zhao, N; Gao, G; Deng, HB; Wang, ZH; Deng, LL; Yang, Y; Lu, CL

Deng, LL; Yang, Y (corresponding author), Harbin Med Univ, Dept Oncol, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China.; Lu, CL (corresponding author), Shanghai Univ Med & Hlth Sci, Shanghai Key Lab Mol Imaging, Shanghai 201318, Peoples R China.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020; 146 (11): 2851

Abstract

Purpose TP53/EGFR co-mutation has been reported to affect the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索